KDNY
Ensign Peak Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-359,480
| Closed | -$13.8M | – | 1785 |
|
|
2023
Q2 | $13.8M | Sell |
359,480
-2,358
| -0.7% | -$90.6K | 0.03% | 348 |
|
|
2023
Q1 | $8.38M | Hold |
361,838
| – | – | 0.02% | 445 |
|
|
2022
Q4 | $9.48M | Buy |
361,838
+124,933
| +53% | +$3.27M | 0.02% | 427 |
|
|
2022
Q3 | $4.66M | Buy |
236,905
+50,808
| +27% | +$999K | 0.01% | 538 |
|
|
2022
Q2 | $3.26M | Hold |
186,097
| – | – | 0.01% | 643 |
|
|
2022
Q1 | $3.05M | Hold |
186,097
| – | – | 0.01% | 726 |
|
|
2021
Q4 | $3.04M | Buy |
186,097
+83,029
| +81% | +$1.35M | 0.01% | 821 |
|
|
2021
Q3 | $1.32M | Hold |
103,068
| – | – | ﹤0.01% | 1319 |
|
|
2021
Q2 | $1.46M | Hold |
103,068
| – | – | ﹤0.01% | 1284 |
|
|
2021
Q1 | $1.6M | Buy |
103,068
+33,580
| +48% | +$522K | ﹤0.01% | 1216 |
|
|
2020
Q4 | $1.1M | Sell |
69,488
-277,952
| -80% | -$4.41M | ﹤0.01% | 1367 |
|
|
2020
Q3 | $845K | Buy |
347,440
+257,080
| +285% | +$625K | ﹤0.01% | 1377 |
|
|
2020
Q2 | $209K | Buy |
+90,360
| New | +$209K | ﹤0.01% | 1577 |
|